Literature DB >> 12887025

Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia.

Periska Tjaniadi1, Murad Lesmana, Decy Subekti, Nunung Machpud, Shinta Komalarini, Wasis Santoso, Cyrus H Simanjuntak, Narain Punjabi, James R Campbell, William K Alexander, H James Beecham, Andrew L Corwin, Buhari A Oyofo.   

Abstract

The antimicrobial susceptibility patterns for 2,812 bacterial pathogens isolated from diarrheal patients admitted to hospitals in several provinces in the cities of Jakarta, Padang, Medan, Denpasar, Pontianak, Makassar, and Batam, Indonesia were analyzed from 1995 to 2001 to determine their changing trends in response to eight antibiotics: ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol, tetracycline, cephalothin, ceftriaxone, norfloxacin, and ciprofloxacin. Vibrio cholerae O1 (37.1%) was the pathogen most frequently detected, followed by Shigella spp. (27.3%), Salmonella spp. (17.7%), V. parahaemolyticus (7.3%), Salmonella typhi (3.9%), Campylobacter jejuni (3.6%), V. cholerae non-O1 (2.4%), and Salmonella paratyphi A (0.7%). Of the 767 Shigella spp. isolated, 82.8% were S. flexneri, 15.0% were S. sonnei, and 2.2% were S. dysenteriae (2.2%). The re-emergence of Shigella dysenteriae was noted in 1998, after an absence of 15 years. Shigella spp. were resistant to ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline. Salmonella typhi and Salmonella paratyphi A were susceptible to all antibiotics tested, while Salmonella spp. showed various resistance patterns according to species grouping. A small number of V. cholerae O1 were resistant to ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline; however, they were still sensitive to ceftriaxon, norfloxacin, and ciprofloxacin. Similar results were shown for V. cholerae non-O1. Campylobacter jejuni showed an increased frequency of resistance to ceftriaxone, norfloxacin, and ciprofloxacin, but was susceptible to erythromycin. This study shows that except for C. jejuni and V. parahaemolyticus, which appeared to be resistant to ciprofloxacin, the majority of the enteric pathogens tested were still susceptible to fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887025

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Bacterial enteropathogens and risk factors associated with childhood diarrhea.

Authors:  Abdel Moati Kh Al Jarousha; Mahmoud A El Jarou; Iyad A El Qouqa
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 1.967

2.  Characterization of extended-spectrum-β-lactamase-producing Vibrio parahaemolyticus.

Authors:  Marcus Ho Yin Wong; Ming Liu; Hoi Ying Wan; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

3.  Emerging fluoroquinolone and macrolide resistance of Campylobacter jejuni and Campylobacter coli isolates and their serotypes in Thai children from 1991 to 2000.

Authors:  O Serichantalergs; A Dalsgaard; L Bodhidatta; S Krasaesub; C Pitarangsi; A Srijan; C J Mason
Journal:  Epidemiol Infect       Date:  2007-02-19       Impact factor: 2.451

4.  High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia.

Authors:  Stephen Baker; Kathryn Holt; Esther van de Vosse; Philippe Roumagnac; Sally Whitehead; Emma King; Philip Ewels; Andrew Keniry; François-Xavier Weill; Diane Lightfoot; Jaap T van Dissel; Kenneth E Sanderson; Jeremy Farrar; Mark Achtman; Panagiotis Deloukas; Gordon Dougan
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

5.  Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals.

Authors:  E S Lestari; J A Severin; P M G Filius; K Kuntaman; D O Duerink; U Hadi; H Wahjono; H A Verbrugh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-13       Impact factor: 3.267

Review 6.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence.

Authors:  Taradon Luangtongkum; Byeonghwa Jeon; Jing Han; Paul Plummer; Catherine M Logue; Qijing Zhang
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

7.  Resistance to ceftriaxone in Vibrio cholerae.

Authors:  Jharna Mandal; V Preethi; R Vasanthraja; S Srinivasan; Subhash Chandra Parija
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

Review 8.  Antimicrobial resistance surveillance in the AFHSC-GEIS network.

Authors:  William G Meyer; Julie A Pavlin; Duane Hospenthal; Clinton K Murray; Kurt Jerke; Anthony Hawksworth; David Metzgar; Todd Myers; Douglas Walsh; Max Wu; Rosa Ergas; Uzo Chukwuma; Steven Tobias; John Klena; Isabelle Nakhla; Maha Talaat; Ryan Maves; Michael Ellis; Glenn Wortmann; David L Blazes; Luther Lindler
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

9.  Predicting treatment cost for bacterial diarrhoea at a regional hospital in Thailand.

Authors:  Arthorn Riewpaiboon; Kwanduen Intraprakan; Sukit Phoungkatesunthorn
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

10.  Prevalence of Shigella serogroups and their antimicrobial resistance patterns in southern Trinidad.

Authors:  Fitzroy A Orrett
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.